We are live on ! Find out more
TCON

TRACON Pharmaceuticals, Inc. Common Stock
TCON

Delisted

TCON was delisted on the 27th of June, 2024.

Back to rankings

21 hedge funds and large institutions have $56.3M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
+21
Holders Change %
–
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
+$24.8M
2
DM
Deerfield Management
New York
+$6.37M
3
VAM
Visium Asset Management
New York
+$6.06M
4
QF
QVT Financial
New York
+$4.84M
5
WSA
Wall Street Associates
California
+$3.28M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$26.5M +$24.8M +9,448 New
DM
2
Deerfield Management
New York
$6.81M +$6.37M +2,425 New
VAM
3
Visium Asset Management
New York
$6.48M +$6.06M +2,307 New
QF
4
QVT Financial
New York
$5M +$4.84M +1,842 New
WSA
5
Wall Street Associates
California
$3.51M +$3.28M +1,250 New
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$2.68M +$2.51M +955 New
CS
7
Candriam SCA
Luxembourg
$1.75M +$1.64M +625 New
PA
8
Perceptive Advisors
New York
$1.4M +$1.31M +500 New
Wells Fargo
9
Wells Fargo
California
$550K +$515K +196 New
NIP
10
Nicholas Investment Partners
California
$421K +$394K +150 New
Millennium Management
11
Millennium Management
New York
$372K +$347K +132 New
SIM
12
Spark Investment Management
New York
$186K +$176K +67 New
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$173K +$163K +62 New
OM
14
Opaleye Management
Massachusetts
$171K +$160K +61 New
VKH
15
Virtu KCG Holdings
New York
$161K +$150K +57 New
UBS Group
16
UBS Group
Switzerland
$36K +$34.2K +13 New
Morgan Stanley
17
Morgan Stanley
New York
$31K +$28.9K +11 New
TRCT
18
Tower Research Capital (TRC)
New York
$23K +$21K +8 New
Citigroup
19
Citigroup
New York
$12K +$10.5K +4 New
BIM
20
BlackRock Investment Management
Delaware
$9K +$7.88K +3 New
PCM
21
Prelude Capital Management
New York
$1K +$2.63K +1 New

TCON Hedge Fund Activity: Q1 2015 in Review

21 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in TRACON Pharmaceuticals, Inc. Common Stock (TCON) for Q1 2015, worth a combined $56.3M.

Buyers outnumbered sellers: 21 funds opened new TCON positions and 0 closed out — a net gain of 21 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was NEA Management Company, opening a new position worth an estimated $24.8M.

  • 21 institutional investors held TRACON Pharmaceuticals, Inc. Common Stock (TCON) as of Q1 2015, up from 0 in Q4 2014.
  • Funds reported $56.3M of TRACON Pharmaceuticals, Inc. Common Stock stock for Q1 2015.
  • 21 funds opened new TRACON Pharmaceuticals, Inc. Common Stock positions in Q1 2015 and 0 closed out, a net change of +21 holders.
  • The largest TRACON Pharmaceuticals, Inc. Common Stock buyer in Q1 2015 was NEA Management Company, an estimated $24.8M added.

Based on aggregated 13F filings for Q1 2015.